5.1 C
Manchester
Saturday, February 7, 2026
BlogForesight supports the partial buy-out of ABL Health with £2.5m investment

Foresight supports the partial buy-out of ABL Health with £2.5m investment

Foresight Group has invested £2.5 million to support the partial buy-out of Bolton-based community healthcare and wellbeing provider ABL Health Limited.

ABL is a provider of community healthcare and wellbeing services across the North of England. The company was founded in 2009 by Denise Leslie and Dr Sheena Bedi, as a means of providing a range of innovative, evidence based, healthy lifestyle, behavioural change and wellbeing programmes including weight management, nutrition support and smoking cessation.

The business has helped approximately 12,000 clients record weight loss in the North West region, mainly in Manchester, St Helens, Wigan and Blackpool, and over 5,000 clients have significantly improved their mental health. On the Wirral, over 3,000 people have stopped smoking as a direct response to the ABL program in the last two years.

Considered one of the regional market leaders in clinically-led, healthcare in the community programmes, ABL operates from its own premises on Redgate Way, Farnworth, Bolton, within the grounds of the Royal Bolton Hospital as well as satellite offices in Manchester, Stockport, the Wirral, St Helens and Hull.

Denise Leslie will continue to lead the business as CEO, with Dr Bedi becoming a non-executive director to provide strategic clinical input. Denise will be supported by a strong second tier management team and a staff base of almost 200. To help drive the growth in the business Foresight has introduced Chris Jessop as Chairman, who has held senior leadership roles in Optima Health, Nuffield Wellbeing, BUPA and AXA PPP.

Foresight’s equity investment, which was supported by a debt package from Barclays, will help with the Company’s geographic expansion, whilst widening its service offering across both the public and private sectors. ABL will continue to focus on the end results of its programmes and on delivering care to the community.

Matthew Pomroy, Investment Manager, Foresight commented: “Foresight is delighted to support ABL, a company that prides itself on its social impact within local communities. We are looking forward to working with Denise and the management team in supporting the company in achieving its growth objectives.”

Denise Leslie, CEO & co-Founder, ABL, commented: “We are excited to have partnered with Foresight and look forward to achieving the next stage of growth in the UK. Foresight has experience in the healthcare sector and have a strong reputation of growing SMEs in the North-West.”

Latest

Science meets romance: A Valentine’s date with a twist

Roses are red, violets are blue - candlelit dinners are boring so here’s something new. If you’re looking to shake things up this Valentine’s Day,...

IBSA UK introduces Hyaluxelle®, a non-hormonal injectable for menopausal vulvovaginal symptoms

An advanced hyaluronic acid-based treatment developed to address the sexual and genital symptoms associated with GSM. IBSA UK, the UK arm of Swiss pharmaceutical company...

Digital agency Bespoke marks 25-year milestone

Bespoke, a UK-based digital agency, is celebrating 25 years in operation, reflecting on its journey from a small start-up to an established business within...

Alpine Group bolsters special risk fire protection services with Channel Fire joining the group

Alpine Group has announced that Channel Fire has joined the business, reinforcing the group’s position in delivering accredited fire protection solutions across technically demanding,...
Subscribe to our newsletter
Business Manchester will use the information you provide on this form to be in touch with you and to provide updates and marketing.
Don't miss

IBSA UK introduces Hyaluxelle®, a non-hormonal injectable for menopausal vulvovaginal symptoms

An advanced hyaluronic acid-based treatment developed to address the sexual and genital symptoms associated with GSM. IBSA UK, the UK arm of Swiss pharmaceutical company...

Science meets romance: A Valentine’s date with a twist

Roses are red, violets are blue - candlelit dinners are boring so here’s something new. If you’re looking to shake things up this Valentine’s Day,...

More News

‘New Maximalism’ set to dominate as Hancocks Jewellers releases 2026 trend outlook

Independent jewellery house Hancocks Jewellers has released its annual trend report, highlighting a major move towards “The New Maximalism”. The forecast points to a...

A car buyer’s guide to PCP finance options in Manchester

Buying a new or used car often involves navigating a complex landscape of finance options. In a major metropolitan area like Manchester, where competition...

Everything Manchester businesses need to know following the Budget

A Stockport insolvency expert has outlined what businesses need to know in the wake of this week's Budget. Chancellor Rachel Reeves finally delivered her much-anticipated financial...